The Stat3 inhibitor F0648-0027 is a potential therapeutic against rheumatoid arthritis
Yosuke Kaneko(Keio University), Takeshi Miyamoto(Kumamoto University Hospital)
Cited by 2
Related Papers
Transient receptor potential (<scp>TRP</scp>) channels: a clinical perspective
|British Journal of Pharmacology|2013|362
The Blimp1–Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis
|The Journal of Experimental Medicine|2010|199
Osteoclast stimulatory transmembrane protein and dendritic cell–specific transmembrane protein cooperatively modulate cell–cell fusion to form osteoclasts and foreign body giant cells
|Journal of Bone and Mineral Research|2012|173
Aldehyde-stress resulting from Aldh2 mutation promotes osteoporosis due to impaired osteoblastogenesis
|Journal of Bone and Mineral Research|2012|78
IL-32-PAR2 axis is an innate immunity sensor providing alternative signaling for LPS-TRIF axis
|Scientific Reports|2013|73